A comparison of covered vs bare expandable stents fbr the treatment of aortoiliac occlusive disease

被引:181
作者
Mwipatayi, Bibombe P. [1 ,2 ]
Thomas, Shannon
Wong, Jackie
Temple, Suzanna E. L. [3 ,4 ]
Vijayan, Vikram
Jackson, Mark [5 ]
Burrows, Sally A. [6 ]
机构
[1] Univ Western Australia, Royal Perth Hosp, Sch Surg, Dept Vasc Surg, Perth, WA 6009, Australia
[2] Univ Western Australia, Fac Med Dent & Hlth Sci, Sch Surg, Perth, WA 6009, Australia
[3] Univ Western Australia, Lung Inst Western Australia, Perth, WA 6009, Australia
[4] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia
[5] Gold Coast Hosp, Dept Vasc Surg, Gold Coast, Qld, Australia
[6] Royal Perth Hosp, Sch Med & Pharmacol, Dept Biostat, Perth, WA, Australia
关键词
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; FEMORAL-ARTERY LESIONS; ILIAC ARTERIES; FOLLOW-UP; AORTOBIFEMORAL BYPASS; PALMAZ STENT; PLACEMENT; IMPLANTATION; EXPERIENCE; STENOSES;
D O I
10.1016/j.jvs.2011.06.097
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Objective: This trial was conducted to determine if covered stents offer a patcncy advantage over bare-metal stents in the treatment of aortoiliac arterial occlusive disease. Methods: The Covered Versus Balloon Expandable Stent Trial (COBEST), a prospective, multicenter, randomized controlled trial, was performed involving 168 iliac arteries in 125 patients with severe aortoiliac occlusive disease who were randomly assigned to receive a covered balloon-expandable stent or bare-metal stent. Patient demographic data, clinical signs and symptoms, Trans Atlantic Inter-Society Consensus (TASC) classification, and preprocedure and postprocedure ankle-brachial index measurements were recorded. The primary end points included freedom from binary restenosis and stent occlusion of the treated area, as determined by ultrasound imaging or quantitative visual angiography, or both. Postprocedural follow-up was at 1, 6, 12, and 18 months. Results: Aortoiliac lesions treated with a covered stent were significantly more likely to remain free from binary restenosis than those that were treated with a bare-metal stent (hazard ratio [HR], 0.35; 95% confidence interval (CI), 0.15-0.82; P = .02). Freedom from occlusion was also higher in lesions treated with covered stents than in those treated with a bare-metal stem (HR, 0.28; 95% CI, 0.07-1.09); however, this did not reach statistical significance (P = .07). Subgroup analyses demonstrated a significant difference in freedom from binary restenosis for covered stems in TASC C and D lesions compared with a bare stem (HR, 0.136; 95% CI, 0.042-0.442). This difference was not demonstrated for TASC B lesions (HR, 0.748; 95% CI, 0.235-2.386). Conclusions: COBEST demonstrates covered and bare-metal stents produce similar and acceptable results for TASC B lesions. However, covered stems perform better for TASC C and D lesions than bare stents in longer-term patcncy and clinical outcome. (J Vasc Surg 2011;54:1561-70.)
引用
收藏
页码:1561 / 1570
页数:10
相关论文
共 36 条
[1]
REPORTING STANDARDS FOR LOWER-EXTREMITY ARTERIAL ENDOVASCULAR PROCEDURES [J].
AHN, SS ;
RUTHERFORD, RB ;
BECKER, GJ ;
COMEROTA, AJ ;
JOHNSTON, KW ;
MCCLEAN, GK ;
SEEGER, JM ;
STRING, ST ;
WHITE, RA ;
WHITTEMORE, AD ;
ZARINS, CK .
JOURNAL OF VASCULAR SURGERY, 1993, 17 (06) :1103-1107
[2]
Armitage P., 2002, Statistical methods in Medical Research, P137
[3]
Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease [J].
Bosch, JL ;
Hunink, MGM .
RADIOLOGY, 1997, 204 (01) :87-96
[4]
LONG-TERM FOLLOW-UP OF THE PALMAZ STENT FOR ILIAC OCCLUSIVE DISEASE [J].
CIKRIT, DF ;
GUSTAFSON, PA ;
DALSING, MC ;
HARRIS, VJ ;
LALKA, SG ;
SAWCHUK, AP ;
TREROTOLA, SO ;
SNIDOW, JJ ;
JOHNSON, MS ;
SOLOOKI, B .
SURGERY, 1995, 118 (04) :608-614
[5]
Results of aortic bifurcation grafts for aortoiliac occlusive disease: A meta-analysis [J].
deVries, SO ;
Hunink, MGM .
JOURNAL OF VASCULAR SURGERY, 1997, 26 (04) :558-569
[6]
Clinical Endpoints in Peripheral Endovascular Revascularization Trials: a Case for Standardized Definitions [J].
Diehm, N. ;
Pattynama, P. M. ;
Jaff, M. R. ;
Cremonesi, A. ;
Becker, G. J. ;
Hopkins, L. N. ;
Mahler, F. ;
Talen, A. ;
Cardella, J. F. ;
Ramee, S. ;
van Sambeek, M. ;
Vermassen, F. ;
Biamino, G. .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2008, 36 (04) :409-419
[7]
DIETHRICH EB, 1995, J ENDOVASC SURG, V2, P266, DOI 10.1583/1074-6218(1995)002<0266:PCACFM>2.0.CO
[8]
2
[9]
Erdoes L S, 1995, Cardiovasc Surg, V3, P277, DOI 10.1016/0967-2109(95)93876-Q
[10]
Pathology of acute and chronic coronary stenting in humans [J].
Farb, A ;
Sangiorgi, G ;
Carter, AJ ;
Walley, VM ;
Edwards, WD ;
Schwartz, RS ;
Virmani, R .
CIRCULATION, 1999, 99 (01) :44-52